Al Hammadi Company For Development And Investment

Name

Al Hammadi Company For Development And Investment

Legal name

Al Hammadi Holding Company

Website

https://alhammadi.com

Company type

Public

Founded year

1985

Operating status

Operating

Headcount range

1,001–5,000 employees

Ownership category

akta.pro rank

Product category

Hospital and Healthcare Services

NAICS

General Medical and Surgical Hospitals (6221)

SIC

Services-Hospitals (8060), Services-Home Health Care Services (8082), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Private/For-Profit Hospital Systems (HLAFAAAF)

Keywords

• Hospital healthcare services
• Inpatient outpatient care
• Pharmaceutical distribution
• Home medical care
• Telemedicine services

Headquarters

HQ city

Riyadh

HQ country

Saudi Arabia

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure, Technology or R&D, Others

Revenue model

1. Hospital / Medical Services: Primary revenue from two operating hospitals in Riyadh offering inpatient (600 rooms) and outpatient (180 clinics) services. Revenue split includes MOH patients, private insurance patients, and direct-pay patients. The Medical Services segment is the largest contributor, with 2026 Q1 revenues of SAR 246.94 million. Segment revenue grew 2.6% YoY in Q1 2026.
2. Pharmaceutical Products: Revenue from pharmaceutical distribution through Pharmaceutical Services Company subsidiary, and retail pharmacy sales. The pharmaceutical segment showed 17.7% YoY growth to SAR 72.15 million in Q1 2026, driven by increased retail sales through the company's subsidiary.
3. Medical Support Services: Revenue from subsidiaries including Arabian Hospitality (hygiene, laundry, food services), Unified Procurement (hospital supplies management), and Construction & Maintenance services.
4. Training & Education Services: Revenue from Support Services Institutes for Training (acquired 100% of Najd Training Institutes in 2020), providing vocational and professional training programs.
5. Sports Medicine Partnership (A.C. Milan): Revenue from SAR 54.5 million multi-year strategic cooperation agreement with A.C. Milan as Official Medical & Rehabilitation Partner in KSA, spanning 8 years through June 2033. The agreement provides medical, rehabilitation and performance-related services.

Go-to-market motion1 record

Distribution channels6 records

Marketing channels6 records

Core offering

Al Hammadi Holding operates an integrated healthcare group headquartered in Riyadh, Saudi Arabia, delivering world-class inpatient and outpatient hospital services through its Al Hammadi Hospitals Group (Al Suwaidi and Al Nuzha hospitals, with Al Olaya under renovation and Al Narjis planned). The group also distributes pharmaceuticals, provides home medical care, telemedicine, medical training, hospital support services, and biopharma R&D across wholly-owned and affiliated subsidiaries.

Product overview

Al Hammadi Holding is an integrated healthcare group and premier hospital operator in Riyadh, Saudi Arabia, operating as a diversified healthcare ecosystem. The company operates through its core hospital network (Al Hammadi Hospital Group comprising Al Suwaidi, Al Nuzha, Al Olaya, and upcoming Al Narjis facilities) alongside multiple subsidiaries and affiliates covering the full healthcare value chain. Key subsidiaries include Pharmaceutical Services, Sudair Pharmaceutical (35% stake), Biopharma Industrial Park, Telemedicine, Home Medical Care, Continuing Medical Education, Support Services Training Institutes, Construction & Maintenance, Unified Procurement, and Arabian Hospitality. The company also holds a 40% stake in Wareed Medical Company (laboratory and home healthcare services). This integrated model provides comprehensive healthcare services from hospital care to pharmaceuticals, medical education, support services, and home healthcare.

Differentiator

Problem solved

Functional benefit

Products and services

• Al Hammadi Hospital Group

Quantifiable outcome

• 18% revenue growth in 2022, reaching SAR 1,122 million from SAR 952 million in 2021.
• +6 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered flagship, core and minor.

• A.C. Milan S.p.A.flagshipStrategic or Co-development Partner · 28 January 2026Al Hammadi Holding signed a multi-year strategic cooperation agreement with A.C. Milan S.p.A. at the MESIF Forum in Riyadh. The company and Al Hammadi Hospitals Group obtained exclusive rights as the Official Medical & Rehabilitation Partner of AC Milan in the Kingdom of Saudi Arabia. The SAR 54.5 million agreement spans 8 years ending June 30, 2033, focusing on developing medical, rehabilitation and performance-related collaboration between the club's medical experts and Al Hammadi's clinical facility in Riyadh. Expected to enhance Al Hammadi's corporate profile in advanced sports medicine and support specialized rehabilitation services development.
• Wareed Medical CompanycoreStrategic or Co-development Partner · 22 January 2026Al Hammadi Holding completed acquisition of a 40% stake in Wareed Medical Company (a limited liability company) for SAR 113 million. The transaction received No-Objection Certificate from the General Authority for Competition. Wareed Medical operates medical laboratory services and home healthcare services across 60 branches in KSA. Al Hammadi subscribed to a capital increase with investment paid in installments (SAR 20 million initial payment, remaining over 5 years). Wareed's revenues grew from SAR 1.2M (2022) to SAR 38.8M (2024). This acquisition expands Al Hammadi's integrated healthcare ecosystem outside hospitals.
• Sudair Pharmaceutical Company (SPC)coreStrategic or Co-development PartnerAl Hammadi Holding owns 35% of Sudair Pharmaceutical Company (SPC), a leading Saudi-based pharmaceutical firm specializing in specialty care medications. SPC focuses on cancer-fighting medications and high-tech treatments for chronic and life-threatening diseases, addressing unmet medical needs in Saudi Arabia and the MENA region. SPC has submitted an IPO application to the Capital Market Authority for listing on the Main Market. SPC's business model includes international partnerships and dedication to quality and innovation, supporting KSA's 2030 vision for better health outcomes.
• BDO Dr. Muhammed Al-Amri & Co.minorOthersBDO Dr. Muhammed Al-Amri & Co. was appointed as the independent auditor for Al Hammadi Holding for fiscal years 2025 and 2026 (fees of SAR 2,184,000 for 2025 and SAR 1,051,100 for 2024). The appointment was approved by the Ordinary General Assembly.

Scale indicators17 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Fakeeh Care Group: Saudi private hospital group (Dr. Soliman Fakeeh Hospital in Jeddah and others), expanding under Vision 2030 with multi-city hospitals. Direct peer in private hospital operations, premium positioning, and integrated medical services.
• Saudi German Health Group (SGH): One of the largest private hospital networks in Saudi Arabia (Batterjee family), operating hospitals in multiple cities. Direct peer in private acute-care hospital operations, serving similar patient mix and competing for the same Vision 2030 expansion awards.
• National Medical Care Company: Tadawul-listed Saudi private hospital operator running multiple facilities including in Riyadh. Directly comparable as a smaller publicly listed private hospital group serving similar insurance/MOH/direct-pay patient mix.
• Mouwasat Medical Services Company: Tadawul-listed private hospital operator headquartered in Dammam with facilities across KSA. Directly comparable as a publicly traded, MOH-contracted, multi-specialty private hospital group with similar revenue mix from insurance and government patients.
• Dallah Healthcare Holding Company: Riyadh-based Tadawul-listed private hospital and healthcare operator (Dallah Hospital, Dr. Mohammed Alfagih). Directly comparable as a competing Riyadh private hospital group with similar B2C/B2B and MOH contract revenue model.
• Dr. Sulaiman Al Habib Medical Services Group: Saudi Arabia's largest private hospital operator, Tadawul-listed, running 7+ hospitals and medical cities across KSA. Directly comparable as a publicly listed for-profit hospital operator serving MOH, insurance, and self-pay patients, with substantially larger scale than Al Hammadi.

Broad incumbents

• NMC Health (UAE): Pre-restructuring, NMC was the largest private healthcare operator in the GCC. Comparable as a regional integrated hospital, clinic and pharma operator with MENA-wide footprint; serves as a strategic reference for GCC private healthcare scale economics though not currently a direct Saudi competitor.
• King Faisal Specialist Hospital and Research Center: Saudi semi-governmental tertiary/quaternary hospital network operated by the government. Broad incumbent providing inpatient specialty care across KSA; competes for tertiary referrals and sets the standard for accreditation that private operators like Al Hammadi benchmark against.

Regional players

• Nahdi Medical Company: Saudi Arabia's largest retail pharmacy chain, with over 1,000 outlets across KSA and adjacent home-health distribution. Comparable as a Saudi healthcare retail/distribution network, primarily focused on pharmacy rather than inpatient care but overlapping with Al Hammadi's pharma distribution segment.

Emerging players

• Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO): Tadawul-listed Saudi pharmaceutical manufacturer and distributor. Comparable as a Saudi pharma operator in the same value chain as Al Hammadi's Pharmaceutical Services subsidiary and Sudair Pharma stake; overlaps on drug distribution and specialty medications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/alhammadiholding
• LinkedInlinkedin.com/company/al-hammadi-hospitals
• Instagraminstagram.com/alhammadiholding

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Al Hammadi Company For Development And Investment